DNMT3B polymorphisms and risk of primary lung cancer

Carcinogenesis

Volumn 26, Issue 2, 2005, Pages 403-409

  Lee, Su Jeong ^a   Jeon, Hyo Sung ^a   Jang, Jin Sung ^b   Park, Sun Ha ^a   Lee, Ga Young ^a   Lee, Byung Heon ^b   Kim, Chang Ho ^b   Kang, Young Mo ^b   Lee, Won Kee ^c   Kam, Sin ^b,c   Park, Rang Woon ^b   Kim, In San ^b   Cho, Young Lae ^b   Jung, Tae Hoon ^b   Park, Jae Yong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B;

ADULT; AGED; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; ETHNIC DIFFERENCE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ALLELES; CASE-CONTROL STUDIES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SMOKING;

EID: 13844267367     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh307     Document Type: Article

References (45)

1. Spitz,M.R., Wei,Q., Dong,Q., Amos,C.I. and Wu,X. (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomark. Prev., 12, 689-698.
2. Moore,L.E., Huang,W.-Y., Chung,J. and Hayes,R.B. (2003) Epidemiologic consideration to assess altered DNA methylation from environmental exposure to cancer. Ann. N. Y. Acad. Sci., 983, 181-196.
3. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nature Genet., 21, 163-167.
4. Baylin,S.B. and Herman,J.G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet., 16, 168-174.
5. Yen,R.W., Vertino,P.M., Nelkin,B.D., Yu,J.J., el Deiry,W., Cumaraswamy,A., Lennon,G.G., Trask,B.J., Celano,P. and Baylin,S.B. (1992) Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res., 20, 2287-2291.
6. Xie,S., Wang,Z., Okano,M., Nogami,M., Li,Y., He,W.-W., Okumura,K. and Li,E. (1999) Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 236, 87-95.
7. Bestor,T.H. (2000) The DNA methyltransferases of mammals. Hum. Mol. Genet., 9, 2395-2402.
8. Rhee,I., Bachman,K.E., Park,B.H. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556.
9. Kim,G.-D., Ni,J., Kelesoglu,N., Roberts,R.J. and Pradhan,S. (2002) Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferase. EMBO J., 21 4183-4195.
10. Bestor,T.H. (1992) Activation of mammalian DNA methyltransferase by cleavage of a Zn binding domain. EMBO J., 11, 2611-2617.
11. Okano,M., Bell,D.W., Haber,D.A. and Li,E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
12. Gama-Sosa,M.A., Slagel,V.A., Trewyn,R.W., Oxenhandler,R., Kuo,K.C., Gehrke,C.W. and Ehrlich,M. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res., 11, 6883-6894.
13. Robertson,K.D. (2001) DNA methylation, methyltransferases, and cancer. Oncogene, 20, 3139-3155.
14. Woodson,K., Mason,J., Choi,S.-W., Hartman,T., Tangrea,J., Virtamo,J., Taylor,P.R. and Albans,D. (2001) Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol. Biomark. Prev., 10, 69-74.
15. Zochbauer-Muller,S., Fong,K.M., Virmani,A.K., Geradts,J., Gazdar,A.F. and Minna,J.D. (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancer. Cancer Res., 61 249-255.
16. Esteller,M. and Herman,J.G. (2002) Cancer as an epigenetic disease: DNA methylation and chromatic alterations in human cancers. J. Pathol., 196, 1-7.
17. Gonzalgo,M.L. and Jones,P.A. (1997) Mutagenic and epigenetic effects of DNA methylation. Mutat. Res., 386, 107-118.
18. Denissenko,M.F., Chen,J.X., Tang,M.-S. and Pfeifer,G.P. (1997) Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc. Natl Acad. Sci. USA, 94, 3893-3898.
19. Yoon,J.-H., Smith,L.E., Feng,Z., Tang,M.-S., Lee,C.-S. and Pfeifer,G.P. (2001) Methylated CpG dinucleotides are the preferenctial targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res., 61, 7110-7117.
20. Robertson,K.D., Uzvolgyi,E., Liang,G., Talmadege,C., Sumegi,J., Gonzales,F.A. and Jones,P.A. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27, 2291-2298.
21. Belinsky,S.A., Nikula,K.J., Baylin,S.B. and Issa,J.-P.J. (1996) Increased cytosine DNA methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl Acad. Sci., 93, 4045-4050.
22. Xie,S., Wang,Z., Okano,M., Nogami,M., Li,Y., He,W.-W., Okumura,K. and Li,E. (1999) Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 236, 87-95.
23. Kanai,Y., Ushijima,S., Kondo,Y., Nakanishi,Y. and Hirohashi,S. (2001) DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer, 91, 205-212.
24. Mizuno,S.-I., Chijiwa,T., Okamura,T., Akashi,K., Fukumaki,Y., Niho,Y. and Sasaki,H. (2001) Expression of DNA methyltransferase DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 97, 1172-1179.
25. Rhee,I., Jair,K.-W., Yen,R.-W.C., Lengauer,C., Herman,J.G., Kinzler,K.W., Vogelstein,B., Baylin,S.B. and Schuebel,K.E. (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003-1007.
26. Kiyohara,C., Otsu,A., Shirakawa,T., Fukuda,S. and Hopkin,J.M. (2002) Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer, 37, 241-256.
27. Shen,H., Wang,L., Spitz,M.R., Hong,W.K., Mao,L. and Wei,Q. (2002) A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res., 62, 4992-4995.
28. Park,J.Y., Park,S.H., Choi,J.E. et al. (2002) Polymorphism of the DNA repair gene XPA and risk of primary lung cancer. Cancer Epidemiol. Biomark. Prev., 11, 993-997.
29. Jeon,H.-S., Kim,K.M., Park,S.H. et al. (2003) Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis, 24, 1677-1681.
30. Lee,C.-T., Kang,K.H., Koh,Y., Chang,J., Chung,H.S., Park,S.K., Yoo,K.-Y. and Song,J.S. (2000) Characteristics of lung cancer in Korea, 1997. Lung Cancer, 30, 15-22.
31. Lewontin, R.C. (1988) On measures of gametic disequilibrium. Genetics, 120, 849-852
32. Stephens,M., Smith,M.J. and Donnelly,P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
33. Yanagisawa,Y., Ito,E., Yuasa,Y. and Maruyama,K. (2002) The human DNA methyltransferases DNMT3A W DNMT3B have two types of promoters with different CpG contents. Biochim. Biophys. Acta, 1577, 457-465.
34. INK4a genes in the development of mouse lung tumors. Exp. Lung Res., 24, 463-479.
35. Hammons,G.J., Yan,Y., Lopatina,N.G., Jin,B., Wise,C., Blann,E.B., Poirier,L.A., Kadlubar,F.F. and Lyn-Cook,B.D. (1999) Increased expression of hepatic DNA methyltransferase in smokers. Cell Biol. Toxicol., 15, 389-394.
36. Grabe,N. (2002) Alibaba2: context specific identification of transcription factor binding sites. In Silico. Biol., 2, S1-1.
37. Gu,J., Spitz,M.R., Yang,F. and Wu,X. (1999) Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis, 20, 1465-1469.
38. Sugimura,H., Kohno,T., Wakai,K. et al. (1999) hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 8, 669-674.
39. Liu,G., Miller,D.P., Zhou,W., Thurston,S.W., Fan,R., Xu,L.-L., Lynch,T.J., Wain,J.C., Su,L. and Christiani,D.C. (2001) Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung cancer. Cancer Res., 61, 8718-8722.
40. Issa,J.P., Baylin,S.B. and Belinsky,S.A. (1996) Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res., 56, 3655-3658.
41. Belinsky,S.A., Nikula,K.J., Baylin,S.B. and Issa,J.P. (1996) Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl Acad. Sci., 93, 4045-4050.
42. Toyooka,S., Maruyama,R., Toyooka,K.O. et al. (2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer, 103, 153-160.
43. 6-methylguanine-DNA methyltransferase in sputum. Cancer Res., 62, 2248-2252.
44. Vineis,P. (1997) Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer, 71, 1-3.
45. Shields,P.G. and Harris,C.C. (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol., 18, 2309-2315.